Parkinson's disease (PD) is a progressive and debilitating chronic disease that affects more
than six million people worldwide, with rising prevalence. The hallmarks of PD are motor …

Following Alzheimer's, Parkinson's disease (PD) is the second-most common
neurodegenerative disorder, sharing an unclear pathophysiology, a multifactorial profile …

Background Antigen-specific neuroinflammation and neurodegeneration are characteristic
for neuroimmunological diseases. In Parkinson's disease (PD) pathogenesis, α-synuclein is …

Neurotransmitters are considered as a fundamental regulator in the process of neuronal
growth, differentiation and survival. Parkinson's Disease (PD) occurs due to extensive …

Parkinson's disease (PD) is a progressive neurodegenerative disorder. The classical
behavioral defects of PD patients involve motor symptoms such as bradykinesia, tremor, and …

Background β-adrenoceptors are widely expressed in different human organs, mediate
important body functions and are targeted by medications for various diseases (such as …

Parkinson's disease (PD) is a neurodegenerative pathology, the origin of which is
associated with the death of neuronal cells involved in the production of dopamine. The …

Parkinson's disease (PD) is a common and progressive neurodegenerative disease, caused
by the loss of dopaminergic neurons in the substantia nigra pars compacta in the midbrain …

Parkinson's disease (PD) is a neurodegenerative disease caused by loss of dopaminergic
neurons in the midbrain. PD is clinically characterized by a variety of motor and nonmotor …

Given the high whittling down rates, high costs, and moderate pace of new medication,
revelation, and improvement, repurposing “old” drugs to treat typical and uncommon …